[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350705-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350705-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","bioinformatics-mining-and-clinical-validation-of-cd274-as-a-prognostic-indicator-in-hepatocellular-carcinoma","Bioinformatics mining and clinical validation of CD274 as a prognostic indicator in hepatocellular carcinoma","","Hepatocellular carcinoma (HCC) has high global incidence and mortality, with limited therapeutic options and poor outcomes, creating a need for reliable prognostic biomarkers. Immune checkpoint molecule CD274 (PD-L1) is associated with poor prognosis in many solid tumours, but its relevance in HCC is controversial and serum levels are unclear. This study integrates TCGA/GTEx bioinformatics with survival modelling and experimental validation using IHC and ELISA.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/bioinformatics-mining-and-clinical-validation-of-cd274-as-a-prognostic-indicator-in-hepatocellular-carcinoma/350705/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/bioinformatics-mining-and-clinical-validation-of-cd274-as-a-prognostic-indicator-in-hepatocellular-carcinoma/350705.png","ImageObject",300,407,{"name":42,"@type":43},"OmBimo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the goal of the study on CD274 in hepatocellular carcinoma?","Question",{"text":63,"@type":64},"To examine CD274 expression patterns and clinical significance in HCC by combining bioinformatics analyses with clinical validation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was CD274/PD-L1 expression validated experimentally?",{"text":68,"@type":64},"PD-L1 protein expression was assessed by immunohistochemistry (IHC) on HCC tissue microarrays, and serum PD-L1 concentrations were measured by ELISA in treatment-naive HCC patients and healthy controls.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationship did the study find between CD274 expression and patient prognosis?",{"text":72,"@type":64},"High CD274 expression was associated with longer overall survival, disease-specific survival, and progression-free interval, and multivariate Cox regression supported CD274 as an independent protective factor for disease-specific survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350705,1790211484,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},962090893581,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Shi et al. BMC Cancer (2026) 26:1013 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-16329-z](https://doi.org/10.1186/s12885-026-16329-z)  \nRESEARCH Open Access  \nBioinformatics mining and clinical validation  of CD274 as a prognostic indicator in hepatocellular carcinoma  \nHansen Shi1,2, Peijun Zhang1, Qiping Wei3, Huixiang He4, Haiqi Wu1, Tianyin Xiao2, Tiancai Liu2*† and Tao Zeng1*†  \nAbstract  \nBackground Hepatocellular carcinoma (HCC) is a malignant tumour with high global incidence and mortality, featuring limited therapeutic options and poor prognosis, which necessitates novel prognostic biomarkers. The immune checkpoint molecule CD274 (Programmed Death-Ligand 1, PD-L1) correlates with poor prognosis in most solid tumours, yet its prognostic value in HCC remains controversial, and circulating levels are unclear. This study aimed to multi-dimensionally investigate CD274’s expression patterns and clinical significance in HCC.  \nMethods Bioinformatics analyses were performed on The cancer genome atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases to screen differentially expressed genes, with functional and pathway annotations via Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Set Enrichment Analysis (GSEA), and Single-Sample Gene Set Enrichment Analysis (ssGSEA) . Survival analysis and univariate/multivariate Cox proportional hazards regression models were used to assess the prognostic value of CD274 . PD-L1 protein expression was validated by immunohistochemistry (IHC) on HCC tissue microarrays. Serum PD-L1 concentrations were detected by ELISA in treatment-naive HCC patients and healthy controls.  \nResults CD274 was lowly expressed in HCC tissues versus normal ones, and its expression correlated with TNF-α/ NF-κB, complement, IFN-γ, adipogenesis and oxidative phosphorylation pathways, as well as lymphocyte-mediated immunity, immune globulin complexes and antigen binding. High CD274 expression negatively correlated with Th17 cells but positively with helper T cells, activated dendritic cells (aDCs), Th1 cells, T cells and macrophages via ssGSEA. Patients with high CD274 expression had longer overall survival (OS), disease-specific survival (DSS) and progressionfree interval (PFI); multivariate Cox regression confirmed CD274 as an independent protective factor for DSS. PD-L1 protein expression showed no significant difference between HCC and normal liver tissues. Serum PD-L1 median was 349.6 pg/mL in HCC patients, significantly higher than 181.3 pg/mL in healthy controls.  \nConclusions This study first identifies a unique “low tissue expression and elevated peripheral blood level” pattern of CD274 in HCC, with intratumoural high expression correlating with favourable prognosis. CD274 may exert distinct  \n†Tiancai Liu and Tao Zeng are co-corresponding authors.  \n*Correspondence: Tiancai Liu [liutc@smu.edu.cn](liutc@smu.edu.cn)[ ](liutc@smu.edu.cn)Tao Zeng [zengt@smu.edu.cn](zengt@smu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the co","cbCaiiI22PHQqsnI","https://ap.wps.com/l/cbCaiiI22PHQqsnI","pdf",3090560,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the goal of the study on CD274 in hepatocellular carcinoma?\",\"answer\":\"To examine CD274 expression patterns and clinical significance in HCC by combining bioinformatics analyses with clinical validation.\"},{\"question\":\"How was CD274/PD-L1 expression validated experimentally?\",\"answer\":\"PD-L1 protein expression was assessed by immunohistochemistry (IHC) on HCC tissue microarrays, and serum PD-L1 concentrations were measured by ELISA in treatment-naive HCC patients and healthy controls.\"},{\"question\":\"What relationship did the study find between CD274 expression and patient prognosis?\",\"answer\":\"High CD274 expression was associated with longer overall survival, disease-specific survival, and progression-free interval, and multivariate Cox regression supported CD274 as an independent protective factor for disease-specific survival.\"}]","Bioinformatics mining and clinical validation of CD274 as a prognostic indicator in hepatocellular carcinoma | PDF",1790090674,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b2ce96c2c07c2276f608927577c6413.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a3a0c3170f73c75523bed95f605064e.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b79393d37df07057af7dcd46c17db34b.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c68a96688b6cf8384aff27ed8b44100.webp",980,1306]